UK Pharma Series A Funding Rounds 2022

Every UK Series A Pharma funding round filed in 2022, sourced direct from Companies House filings. Updated weekly.

UK Pharma Series A Funding Rounds 2022

CompanyRaisedRoundDate
Kaerus Bioscience£725kSeries A2023/01/13
Sitryx Therapeutics£3.0MSeries A2023/01/07
My-T Bio£5.5MSeries A2023/01/03
Re-Vana Therapeutics£5.5MSeries A2022/11/30
Mosaic Therapeutics£10.0MSeries A2022/10/28
Kesmalea Therapeutics£5.0MCash and a share swapSeries A2022/10/18
Kaerus Bioscience£132kSeries A2022/09/26
Novalgen£4.3MSeries A2022/08/25
Cambridge Allergy£471kSeries A2022/08/04
Resolution Therapeutics£12.6MSeries A2022/08/04
Nrg Therapeutics£17.6MSeries A2022/07/06
Zura Bio£7.5MSeries A2022/04/12
Oxford Medical Products£2.5MSeries A2022/02/20
Thirtyfivebio£12.5MSeries A2022/02/18
Alchemab Therapeutics£20.0MSeries A2022/02/16
Gylden Pharma£10.1MSeries A2022/02/04
Resolution Therapeutics£3.0MSeries A2022/01/24
Oak Hill Bio£739kSeries A2022/01/24

More Pharma funding